Dividend
-
-
-
-
-
-
-
Qiagen launches new bloodstream infection panel in Europe
-
-
-
-
-
-
-
QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows
-
-
-
-
-
-
-
QIAGEN lowers 2026 outlook as QuantiFERON immigration testing drops
-
-
-
-
-
-
-
QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars
-
-
-
-
-
-
-
QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability
-
-
-
-
-
-
-
QIAGEN Announces Plans to Return Approximately $250 Million to Shareholders Via Synthetic Share Repurchase Proposal
-
-
-
-
451,168 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

